Bernard J. Birkett
Net Worth
Last updated:
What is Bernard J. Birkett net worth?
The estimated net worth of Mr. Bernard J. Birkett is at least $18,566,606 as of 2 Aug 2023. He owns shares worth $1,078,315 as insider, has earned $13,108,291 from insider trading and has received compensation worth at least $4,380,000 in West Pharmaceutical Services, Inc..
What is the salary of Bernard J. Birkett?
Mr. Bernard J. Birkett salary is $1,460,000 per year as Senior Vice President & Chief Financial Officer in West Pharmaceutical Services, Inc..
How old is Bernard J. Birkett?
Mr. Bernard J. Birkett is 56 years old, born in 1969.
What stocks does Bernard J. Birkett currently own?
As insider, Mr. Bernard J. Birkett owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| West Pharmaceutical Services, Inc. (WST) | Senior Vice President & Chief Financial Officer | 4,366 | $246.98 | $1,078,315 |
What does West Pharmaceutical Services, Inc. do?
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Bernard J. Birkett insider trading
West Pharmaceutical Services, Inc.
Mr. Bernard J. Birkett has made 6 insider trades between 2022-2023, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 22,134 units of WST stock on 2 Aug 2023. As of 2 Aug 2023 he still owns at least 4,366 units of WST stock.
West Pharmaceutical Services key executives
West Pharmaceutical Services, Inc. executives and other stock owners filed with the SEC:
- Mr. Bernard J. Birkett (56) Senior Vice President & Chief Financial Officer
- Mr. David A. Montecalvo (60) Senior Vice President and Chief Operations & Supply Chain Officer
- Mr. Eric M. Green (55) Pres, Chief Executive Officer & Director
- Mr. Silji Abraham (53) Senior Vice President & Chief Technology Officer